Anixa Biosciences Inc Quarterly Revenue from Contract with Customer, Excluding Assessed Tax in USD from Q4 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
Summary
Anixa Biosciences Inc annual/quarterly Revenue from Contract with Customer, Excluding Assessed Tax history and growth rate from Q4 2020 to Q1 2023.
  • Anixa Biosciences Inc Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending April 30, 2023 was $210K.
  • Anixa Biosciences Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $210K.
  • Anixa Biosciences Inc annual Revenue from Contract with Customer, Excluding Assessed Tax for 2021 was $512K.
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $210K Feb 1, 2023 Apr 30, 2023 10-Q 2024-06-04
Q4 2020 $513K Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.